These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27541678)

  • 1. Usefulness of cardiac resynchronization therapy in the recovery of patients with left ventricular assist devices.
    Verreault-Julien L; Philippon F; Charbonneau É; Kalavrouziotis D; LeRoux É; Sarrazin JF; Dubois M; Voisine P; Sénéchal M
    Int J Cardiol; 2016 Nov; 223():297-298. PubMed ID: 27541678
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy.
    Santulli G; D'Ascia C
    Heart; 2012 Mar; 98(6):517; author reply 517. PubMed ID: 22350031
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of speckle-strain in a multiparametric approach to dyssynchrony imaging.
    Marwick TH
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):375-7. PubMed ID: 21492812
    [No Abstract]   [Full Text] [Related]  

  • 5. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.
    Rickard J; Johnston DR; Price J; Tedford R; Baranowski B; Bassiouny M; Cantillon D; Grimm RA; Tang WHW; Varma N; Wilkoff BL
    Heart Rhythm; 2015 Mar; 12(3):517-523. PubMed ID: 25460866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.
    Kutyifa V; Solomon SD; Bourgoun M; Shah AM; Pouleur AC; Knappe D; McNitt S; Wang PJ; Merkely B; Pfeffer M; Moss AJ; Zareba W
    Heart Rhythm; 2013 Mar; 10(3):354-60. PubMed ID: 23174486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal left ventricular lead placement for cardiac resynchronization therapy in postmyocardial infarction patients.
    Muto C; Solimene F; Russo V; Nigro G; Rago A; Chianese R; Chiariello P; Ciardiello C; Caliendo L
    Future Cardiol; 2018 May; 14(3):215-224. PubMed ID: 29767542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
    Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D
    Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cardiac resynchronization therapy in an end-stage heart failure patient with a left ventricular assist device as a bridge to recovery. A case report.
    Muratsu J; Hara M; Mizote I; Asano Y; Sakata Y; Saito S; Matsumiya G; Sawa Y; Komuro I
    Int Heart J; 2011; 52(4):246-7. PubMed ID: 21828953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-site pacing: a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy.
    Nishimura T; Kyo S
    J Artif Organs; 2010 Apr; 13(1):54-7. PubMed ID: 20174955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy reduces left ventricular energy loss.
    Kakizaki R; Nabeta T; Ishii S; Koitabashi T; Itatani K; Inomata T; Ako J
    Int J Cardiol; 2016 Oct; 221():546-8. PubMed ID: 27414737
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of global longitudinal strain in heart failure patients treated with cardiac resynchronization therapy.
    Khidir MJH; Abou R; Yilmaz D; Ajmone Marsan N; Delgado V; Bax JJ
    Heart Rhythm; 2018 Oct; 15(10):1533-1539. PubMed ID: 29604420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results.
    Perri G; Filippelli S; Adorisio R; Iacobelli R; Iodice F; Testa G; Paglietti MG; D'Amario D; Massetti M; Amodeo A
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):669-674. PubMed ID: 27692952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular endocardial pacing via the interventricular septum for cardiac resynchronization therapy: first report.
    Gamble JH; Bashir Y; Rajappan K; Betts TR
    Heart Rhythm; 2013 Dec; 10(12):1812-4. PubMed ID: 23891954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.